Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004691 |
---|---|
Receipt number | R000005583 |
Scientific Title | A phase 2 study of combination chemotherapy for hepatocellular carcinoma using Miripla (SM11355) and IA-call (DDP-H) |
Date of disclosure of the study information | 2011/09/18 |
Last modified on | 2017/04/01 16:24:16 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/12/09 00:58:15 | ||
2 | Update | 2011/09/18 23:07:48 | Post marketing survey by drug manufacture etc., specified by Japanese law. Date of disclosure of the study information |
|
3 | Update | 2012/01/10 23:50:11 | Recruitment status |
|
4 | Update | 2017/04/01 16:18:03 | Organization Organization Division name Address Address TEL Last name of contact person Last name of contact person Organization Organization Division name Address Address TEL Organization Organization Division name Address Address TEL Name of primary person or sponsor Organization Institutions |
|
5 | Update | 2017/04/01 16:24:16 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |